AbbVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

AbbVie (NYSE: ABBV) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 5:00 p.m. CT. The presentation will be led by Richard A. Gonzalez, chairman and CEO. Investors can access a live audio webcast via AbbVie's Investor Relations website, with an archived version available later that day. AbbVie focuses on innovative medicine across critical areas including immunology, oncology, and more. For updates, visit abbvie.com.

News Market Reaction – ABBV

+0.48%

+0.48% Session move

In the trading session that priced this news, ABBV gained 0.48%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH CHICAGO, Ill., Jan. 3, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Richard A. Gonzalez, chairman and chief executive officer, will present at 5:00 p.m. CT.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301711230.html

SOURCE AbbVie

FAQ

When will AbbVie present at the J.P. Morgan Healthcare Conference 2023?

AbbVie will present on January 10, 2023.

What time is AbbVie's presentation at the conference?

AbbVie's presentation is scheduled for 5:00 p.m. CT.

Who will present for AbbVie at the conference?

Richard A. Gonzalez, chairman and CEO, will present.

Where can I listen to AbbVie's presentation live?

The presentation can be accessed via AbbVie's Investor Relations website.

Will the presentation be available after the live event?

Yes, an archived edition will be available later that day.